KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Total Non-Current Liabilities (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $69.2 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 401.72% to $69.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69.2 million through Dec 2025, up 401.72% year-over-year, with the annual reading at $69.2 million for FY2025, 401.72% up from the prior year.
  • Total Non-Current Liabilities hit $69.2 million in Q4 2025 for ClearPoint Neuro, up from $44.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $69.2 million in Q4 2025 to a low of $13.8 million in Q4 2024.